Prism Medico and Pharmacy Ltd

BSE: 512217

26

total announcements

PRISMMEDI.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 20 Oct 2026

Market Cap

₹20 Cr

EPS (TTM)

₹-0.07

52W Low

₹15.51

52W High

₹34.65

Dividend Yield

0.00%

Beta

0.44

Price / Book

1.3

Revenue (TTM)

₹85,47,000.00

Gross Margin

16.78%

Operating Margin

-32.48%

BSEBoard MeetingResults24 Aug 2026

Prism Medico and Pharmacy Ltd

1. Considered & approved: (i) Director''s Report for the F.Y. ended March 31, 2026 (ii) notice of 24th AGM to be held on September 19, 2026 at 12:30 P.M. through VC/OAVM 2. Fixed date ....

Prism Medico and Pharmacy Ltd's Board of Directors approved the Director's Report for FY ended March 31, 2026, and the notice of 24th AGM to be held on September 19, 2026. They also fixed the date for closure of Register of Members and Share Transfer Books, and appointed a scrutinizer for e-voting. Additionally, they recommended the re-appointment of Statutory Auditors and Secretarial Auditors, and variation in the objects of the Preferential Issue.

Read more →📎 1 attachment
BSEBoard MeetingResults19 Aug 2026

Prism Medico and Pharmacy Ltd

Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2026 ,inter alia, to consider and approve ? To consider and ....

Prism Medico and Pharmacy Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2026 to consider and approve various matters including Director's Report, Annual General Meeting, and auditor appointments.

Read more →📎 1 attachment
BSECompany UpdateRegulatory21 Jul 2026

Prism Medico and Pharmacy Ltd

Dear Sir/Madam, Please find the attache statements of investor complaints for the quarter ended 30th June, 2026. You are requested to kindly take the same on record and oblige. Thanking ....

Prism Medico and Pharmacy Ltd has submitted a report on investor complaints for the quarter ended 30th June, 2026, as per Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The report shows zero pending, received, and disposed-off complaints, with no unresolved complaints at the end of the quarter.

Read more →📎 1 attachment
← PreviousPage 2 of 2